HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soluble LAG-3 and Toll-interacting protein: Novel upstream neuro-inflammatory markers in Parkinson's disease.

AbstractINTRODUCTION:
There is some evidence regarding the role of LAG-3, TLR mediated neuroinflammation in PD.
METHODS:
sLAG-3, TOLLIP, NLRP3 levels were measured in PD and healthy controls.
RESULTS:
These markers were significantly higher in PD and were associated with progression.
CONCLUSION:
sLAG3 and TOLLIP are involved in the NLRP3 mediated inflammatory activation in PD.
AuthorsAkash Roy, Supriyo Choudhury, Rebecca Banerjee, Purba Basu, Hrishikesh Kumar
JournalParkinsonism & related disorders (Parkinsonism Relat Disord) Vol. 91 Pg. 121-123 (10 2021) ISSN: 1873-5126 [Electronic] England
PMID34601340 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Elsevier Ltd. All rights reserved.
Chemical References
  • Antigens, CD
  • Biomarkers
  • Intracellular Signaling Peptides and Proteins
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • TOLLIP protein, human
  • Lymphocyte Activation Gene 3 Protein
  • Lag3 protein, human
  • soluble LAG-3 protein, human
Topics
  • Antigens, CD (blood)
  • Biomarkers (blood)
  • Case-Control Studies
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins (blood)
  • Male
  • NLR Family, Pyrin Domain-Containing 3 Protein (blood)
  • Neuroinflammatory Diseases (genetics)
  • Parkinson Disease (blood, genetics)
  • Lymphocyte Activation Gene 3 Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: